Medpace Holdings Inc (MEDP)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$412.57
Buy
$650.00
$-8.25 (-1.46%)
Prices updated at 12 Dec 2025, 22:11 EST
| Prices minimum 15 mins delay
Prices in USD
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 31.12 |
| 2023 | 27.81 |
| 2022 | 29.62 |
| 2021 | 28.73 |
| 2020 | 30.10 |
| 2019 | 28.54 |
| 2018 | 30.59 |
| 2017 | 40.05 |
| 2016 | 40.83 |
| 2015 | 43.56 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 7.16 |
| 2024 | 5.13 |
| 2023 | 5.50 |
| 2022 | 6.22 |
| 2021 | 7.49 |
| 2020 | 5.86 |
| 2019 | 3.82 |
| 2018 | 3.14 |
| 2017 | 3.44 |
| 2016 | 3.59 |
Price/Forward earnings (YTD)
34.97
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 21.52 |
| 2023 | 18.78 |
| 2022 | 16.28 |
| 2021 | 11.89 |
| 2020 | 11.44 |
| 2019 | 9.49 |
| 2018 | 7.60 |
| 2017 | 4.05 |
| 2016 | 1.36 |
| 2015 | -0.83 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 2.54 |
| 2023 | 2.96 |
| 2022 | 3.50 |
| 2021 | 1.74 |
| 2020 | 1.73 |
| 2019 | 1.57 |
| 2018 | 1.64 |
| 2017 | 1.89 |
| 2016 | 1.60 |
| 2015 | 2.38 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
